LifeCannMD

FEBRUARY 27, 2024

The Science Behind Medical Marijuana and Its Effects on Epileptic Seizures Medical Marijuana has garnered significant attention for its benefits in treating epilepsy and seizures. CBD’s ability to reduce glutamate levels and enhance GABA activity can help to reduce seizures.

Clinical Trials 59

Clinical Trials Epilepsy Marijuana Research and Development 59

Cannabis Law Report

SEPTEMBER 13, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021. in the blood. For more information, visit www.mymd.com.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

MMJ Recs

NOVEMBER 20, 2023

While there are over 100 different cannabinoids identified in cannabis, the two most well-known and widely studied are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). On the other hand, CBD is non-psychoactive and has gained attention for its potential therapeutic applications. Image by Pfüderi from Pixabay.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

TheAnswerPage

MARCH 11, 2022

In the clinical trials evaluating a purified CBD product (Epidiolex) in epilepsy patients, side effects including sedation, decreased appetite, diarrhea, sleep disturbance, infections, pneumonia, viral infections and weight loss were reported. ” Kirkland AE, Fadus MC et al. Psych Resear. 308 (2022).

Clinical Trials 52

Clinical Trials Epilepsy Events Sleep 52

Cannabis Life Network

MAY 27, 2021

Early scientific research and clinical trials have shown promise in their ability to help supplement treatments for people with various neurological disorders with cannabidiol (CBD). CBD is a naturally occurring chemical compound found in cannabis, such as hemp.

Clinical Trials 76

Clinical Trials CBD Treatment Hemp 76

Canna Care Docs

JUNE 18, 2018

For those who might be exploring the benefits of cannabis or are considering its many therapeutic effects, Cannabidiol, often abbreviated as CBD is especially important for cannabis patients. CBD possess a wide array of therapeutic effects, without the psychoactive and intoxicating effects that are typically associated with cannabis.

Clinical Trials 75

Clinical Trials CBD Epilepsy Patients 75

TheAnswerPage

FEBRUARY 8, 2022

Do individuals who abruptly stop taking CBD experience physical withdrawal symptoms? No, not according to a 2020 clinical trial which involved the abrupt withdrawal of CBD after four-weeks of use (750 mg twice daily taken orally). Abrupt withdrawal of cannabidiol (CBD): a randomized trial. Epilepsy Behav.

Clinical Trials 59

Clinical Trials Epilepsy CBD 59

TheAnswerPage

MAY 25, 2022

The results of recent clinical trials indicate that Cannabidiol (CBD) reduces seizures among patients with refractory epilepsies of various etiologies. Most of these clinical studies report efficacy over short time periods (. The long-term efficacy of cannabidiol in the treatment of refractory epilepsy.

Clinical Trials 52

Clinical Trials Epilepsy Treatment CBD 52

The Cannigma

JUNE 15, 2021

Close behind it — in both regards — is CBD, which despite having been studied for decades, has only become the center of a billion dollar industry in recent years. Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. CBD vs THC. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JULY 27, 2021

and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Under the Leadership of Nicolas Schlienz, Ph.D., About Realm of Caring.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

TheAnswerPage

JUNE 19, 2021

The results of recent clinical trials indicate that Cannabidiol (CBD) reduces seizures among patients with refractory epilepsies of various etiologies. Most of these clinical studies report efficacy over short time periods (. The long-term efficacy of cannabidiol in the treatment of refractory epilepsy.

Clinical Trials 52

Clinical Trials Epilepsy Treatment CBD 52

Cannabis Law Report

SEPTEMBER 9, 2021

MyMD to highlight its development pipeline for MYMD-1, an immunometabolic regulator, and Supera-CBD, a synthetic cannabidiol derivative. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, will present at the H.C. For more information, visit www.mymd.com.

Pharmaceutical 97

Pharmaceutical Clinical Trials Chronic Pain Epilepsy 97

Healer

DECEMBER 17, 2021

Studies have shown CBD to be a safe substance, but as with any new drug, you must make sure it doesn’t negatively interact with other medications. Numerous studies have shown that CBD is a safe, non-impairing, and non-habit-forming substance. Most often, CBD interacts with other drugs via liver metabolism. By Dr. Dustin Sulak.

CBD 98

CBD THC Conditions Medicine 98

Cannabis Law Report

JUNE 7, 2022

Cannabidiol or CBD is a compound derived from the Cannabis sativa plant, more prominently known as cannabis or hemp. On the contrary, researchers are leaning more towards CBD as a beneficial chemical with therapeutic effects on various physical and mental health problems, from anxiety to chronic pain. Potential Benefits of CBD.

Chronic Pain 52

Chronic Pain CBD Digestion Edibles 52

Cannabis Law Report

SEPTEMBER 20, 2021

(“Nanomerics”) to use Nanomeric’s molecular envelope platform technology (MET) for the nasal delivery of a cannabidiol (CBD) for the management of epilepsy in adults and children. VRP324 uses a preassembled device and cartridge to propel the CBD powder formulation into the nose to the brain via the olfactory nerve/bulb.

Epilepsy 52

Epilepsy Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

NOVEMBER 25, 2021

CBD is all the rage, and has been for quite some time. Most cannabis by-products are legal these days, and the CBD industry has been booming. Here are a few reasons why CBD products are more popular than ever this year. Epilepsy Treatment. However, hope in the form of CBD seems to be on the way.

CBD 52

CBD Clinical Trials Epilepsy Chronic Pain 52

Cannabis Law Report

DECEMBER 28, 2021

This is all thanks to CBD, or cannabidiol, one of the most important cannabinoids identified in cannabis plants. But what makes CBD different from other cannabinoids is its therapeutic properties. So, no wonder CBD-related products are everywhere in the form of tinctures, gummies, oil, cosmetics, and a lot more.

CBD 52

CBD Clinical Trials Consumption Chronic Pain 52

MMJ Recs

DECEMBER 28, 2023

Strains with a balanced THC and CBD ratio are often recommended for their synergistic effects in pain relief without the intense psychoactive experience. CBD, a non-psychoactive cannabinoid, has gained attention for its anti-anxiety effects. Medical cannabis, with its anxiolytic properties, offers a potential solution.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Cannabis Law Report

SEPTEMBER 22, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced new data demonstrating Supera-CBD’s superior potency over CBD by factor of 8,000 times. Watch how Supera-CBD works. “We Chief Scientific Officer of MyMD. “We

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Alchimia

FEBRUARY 1, 2022

CBD is one of the principal cannabinoids found in cannabis and, along with THC, one of its best-known compounds. Therapeutic properties of CBD. The truth is that CBD has proven to have multiple properties that are useful both in the recreational field (since it modulates the adverse effects of THC) and in the medicinal field.

CBD 52

CBD Epilepsy Research and Development Cannabinoids 52

CannaMD

AUGUST 8, 2020

In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. So sit back, relax – and if you can’t relax, grab some CBD! What is CBD? Let’s clear up one of the biggest sources of confusion right off the bat: CBD is a cannabis compound called cannabidiol.

CBD 100

CBD DEA Research and Development Hemp 100

MedicalJane

OCTOBER 3, 2019

The United States Department of Defense and GW Pharmaceuticals are collaborating on a new clinical trial at the Montefiore Medical Center in New York. Dr. Eric Hollander, the Director of the Autism and Obsessive Compulsive Spectrum Program and Anxiety and Depression Program at Montefiore Hospital, is leading the clinical trial.

Clinical Trials 74

Clinical Trials Epilepsy Pharmaceutical Treatment 74

Otherside Farms

APRIL 14, 2020

Research on CBD ( cannabidiol ) shows that it has vast therapeutic properties. Some of the findings of different studies suggest that vaping CBD could have significant health benefits in treating and managing various health disorders. According to a study done in Brazil in 1973, CBD was found to block or lower convulsions in rodents.

CBD 52

CBD Research and Development Sleep Clinical Trials 52

The Cannigma

MARCH 7, 2022

So much attention is placed upon THC and CBD that sometimes the less abundant cannabinoids are forgotten about or not appreciated fully. These effects are shared by THC and CBD, but are typically less potent. However the combination of CBN and CBD produced longer-lasting results, supporting the entourage effect theory.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. tetrahydrocannabinol (THC).

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

NOVEMBER 1, 2021

Here at CLR we wouldn’t take the risk of importing CBD products into HK unless they were made using precision fermentation. CBD is legal and used in beauty products, drinks and oils, but it must be ‘100 per cent pure’. Cannabis extract CBD’s use in Hong Kong is growing – how to consume it. per cent.

Wellness and Beauty 52

Wellness and Beauty CBD Clinical Trials Pharmaceutical 52

Cannabis Law Report

AUGUST 19, 2021

Here we’re just talking about CBD. Cannabidiol or CBD, which is most commonly sold as oil at high street retailers, is one of the active ingredients of non-psychoactive cannabis. Cannabidiol or CBD, which is most commonly sold as oil at high street retailers, is one of the active ingredients of non-psychoactive cannabis.

Cannabinoids 105

Cannabinoids Seed-To-Sale Clinical Trials CBD 105

Cannabis Law Report

JANUARY 10, 2022

This high share is attributable to the rising adoption of THCV for various applications such as epilepsy, arthritis, metabolic disorders, neurological disorders, and pain management. Rising clinical trials is thus anticipated to boost the adoption and penetration of rare cannabis derivatives in the forthcoming years.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

Leafwell

MARCH 11, 2019

Cannabidiol (CBD) is still a big mystery in many ways.

Clinical Trials 68

Clinical Trials CBD Cannabinoids Chronic Pain 68

Healer

DECEMBER 17, 2021

Studies have shown CBD to be a safe substance, but as with any new drug, you must make sure it doesn’t negatively interact with other medications. Numerous studies have shown that CBD is a safe, non-impairing, and non-habit-forming substance. Most often, CBD interacts with other drugs via liver metabolism. By Dr. Dustin Sulak.

CBD 52

CBD THC Conditions Medicine 52

Cannabis Law Report

AUGUST 24, 2021

The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. Based on a novel synthetic derivative of cannabidiol (CBD), Supera-CBD is being developed to address the rapidly growing CBD market, which includes both FDA approved drugs and CBD products not currently regulated as drugs.

Pharmaceutical 98

Pharmaceutical Clinical Trials Chronic Pain CBD 98

The Joint Blog

JANUARY 12, 2020

The market for CBD pet products has exploded in recent years, with numerous success stories. However, researchers warn that not only are not all CBD pet products made equally, but some contain no CBD at all. Because the federal government has yet to establish standards for CBD, these companies can get away with it.

Pets 36

Pets CBD Clinical Trials Research and Development 36

MGC Pharma

FEBRUARY 20, 2018

Cannabis is an effective tool for the treatment of topical skin conditions In a recent study by undertaken by MGC Pharma, our dermatologists found that CBD is effective in providing relief for relief for dry, red, flakey, oily and acne prone skin through CBD skincare.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

The Joint Blog

APRIL 22, 2022

Cannabidiol, also popularly known as CBD, is a chemical compound derived from cannabis Sativa plants. However, before consuming CBD in any form, you must seek your doctor’s advice and buy the best CBD oil on the market. Many companies offer CBD oil in multiple forms for general use. Forms of CBD. Treats Epilepsy.

Oil 26

Oil CBD Topical Clinical Trials 26

Cannabis Law Report

OCTOBER 19, 2021

will discuss the multiple indications for each of MyMD’s novel drug candidates, MYMD-1 and Supera-CBD. MyMD expects to launch two Phase 2 trials during the current quarter for MYMD-1 – one for delaying aging and prolonging healthy lifespan, and the other for post- COVID-19 depression and cytokine elevation. About Supera-CBD.

Pharmaceutical 52

Pharmaceutical Therapy Clinical Trials Chronic Pain 52

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

The two active cannabinoids in marijuana are cannabidiol (CBD) and tetrahydrocannabinol (THC), the latter of which causes psychoactive effects while the former does not. CBD seems to help the body’s natural endocannabinoid system return to normalcy and function better. CBD for Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

The Joint Blog

JANUARY 31, 2021

According to a new study published in the Journal of Medical Case Reports , the daily use of high-CBD (cannabidiol) marijuana extracts is associated with improvements in the behavioral symptoms related to autism spectrum disorder (ASD). The individual was given very low-doses of marijuana extracts, no larger than 0.2 ml twice daily.

Epilepsy 62

Epilepsy Extraction Research and Development Clinical Trials 62